阶段到阶段:在高风险的MDS试验中,与低甲基化剂的药物组合进行导航,以获得最佳结果
Almuth Maria Anni Merz1, Marie Sébert2, Jan Sonntag1
1Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Disease, University Hospital of Leipzig, Leipzig, Germany.
Cancer treatment reviews
|January 4, 2024
概括
高风险骨髓质瘤 (HR MDS) 治疗面临研究设计挑战. 本综述分析了负面临床试验,并建议对未来的HR MDS研究进行优化.
科学领域:
- 血液学 血液学 血液学
- 临床试验设计 临床试验设计
- 在瘤学瘤学.
背景情况:
- 高风险骨髓质新生体 (HR MDS) 的治疗环境正在发展.
- 国际预测评分系统 (IPSS) 已更新为其分子修订版 (IPSS-M).
- 分类的复杂性来自于MDS/AML重叠和包括慢性骨髓单细胞白血病 (CMML).
研究的目的:
- 为HR MDS提供负面临床试验的概述.
- 分析试验失败的潜在原因.
- 探索在HR MDS中优化未来临床试验设计的策略.
主要方法:
- 审查HR MDS治疗的最新发展.
- 分析研究设计中的挑战,包括不断变化的药物组合和预后评分系统.
- 检查分类复杂性,并与AML标准保持一致.
- 对不良事件报告标准的评估.
主要成果:
- 随着药物组合与低甲基化剂 (HMA) 的发展,研究设计面临挑战.
- 从IPSS向IPSS-M的转变影响了研究和临床实践.
- 在AML和MDS之间治疗进展的差异,以及HR MDS中的血液毒性,需要详细的试验设计.
- 对不良事件报告 (例如,CTCAE) 的清晰度对于有效的治疗策略至关重要.
结论:
- 在HR MDS的负面临床试验强调了改善研究设计的必要性.
- 解决分类复杂性和标准化报告是必不可少的.
- 优化未来的临床试验对于推进HR MDS患者护理至关重要.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:17Phase II Reactions: Methylation Reactions
193
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
193
01:27Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
01:28Drug Therapy
45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
45